Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.312 USD | -1.27% |
|
+7.66% | -60.20% |
06-17 | Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy | MT |
05-10 | Coeptis Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 11.73M 16.09M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.46M | Net income 2025 * | -15M -20.57M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.22
x | P/E ratio 2025 * |
-1.86
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.36% |
1 day | -1.27% | ||
1 week | +7.66% | ||
Current month | +15.38% | ||
1 month | -6.19% | ||
3 months | -3.05% | ||
6 months | -64.14% | ||
Current year | -60.20% |
![Extreme 0.282](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 22-10-27 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 23-05-16 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 22-10-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 22-10-27 | |
Director/Board Member | 55 | 22-10-27 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 22-10-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-18 | 0.312 | -1.27% | 11 027 |
24-06-17 | 0.316 | -3.95% | 560,187 |
24-06-14 | 0.329 | +6.80% | 243,794 |
24-06-13 | 0.3081 | +4.74% | 396,204 |
24-06-12 | 0.2941 | +1.48% | 302,920 |
Delayed Quote Nasdaq, June 18, 2024 at 09:46 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.20% | 11.73M | |
+52.28% | 797B | |
+40.80% | 628B | |
-6.86% | 351B | |
+17.82% | 323B | |
+11.12% | 300B | |
+17.17% | 244B | |
+0.94% | 223B | |
+5.35% | 163B | |
-5.02% | 153B |
- Stock Market
- Equities
- COEP Stock